TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG Trademark
TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is a USPTO trademark filed by Genentech, Inc.. Status: Registered.
Trademark Facts
| Mark | TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG |
|---|---|
| Serial Number | 90318619 |
| Registration Number | 6506351 |
| Status | Registered |
| Filing Date | 2020-11-13 |
| Registration Date | 2021-10-05 |
| Mark Type | Combined |
| Nice Classes | 044 (Medical Services) |
| Owner | Genentech, Inc. |
| Attorney of Record | Gregory Zinkl |
| Prosecution Events | 35 |
| Latest Event | REAP on 2026-04-09 |
Goods & Services
Class 044: Providing online information services, namely, prescription drug information in relation to the treatment and symptoms of disorders relating to oncology, autoimmune, or inflammatory diseases